Four things to know:
1. The company’s net sales of $233.4 million was an 11.5 percent decrease from the same time last year.
2. Third-party spine and dental sales decreased year over year as well. Spine sales were $115.2 million, a 19.6 percent dip, while dental sales were $118.2 million, a 1.8 percent decrease.
3. ZimVie saw an $8.7 million net loss in the second quarter. It was primarily because of a decline in spine business, according to the report.
4. The company’s full-year guidance was adjusted, and the projected revenue for 2022 fell from $1 billion to an estimated $915 million to $930 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
